Addressing Health Equity Disparities Through
Direct Pharmacist Intervention

  • June 02, 2021
  • 2:00 PM – 3:00 PM ET
  • Online

Health equity – the idea that every person should have a fair and just opportunity to be as healthy as possible – has been a focus and a goal of public health policies for decades. Due in part to the effects of social determinants of health – nonmedical factors affecting health – some racial and ethnic minorities in our country experience a disproportionate burden of preventable disease, death, and disability as compared with non-minorities.

Pharmacies have an opportunity to positively impact and address the systemic health disparities in communities of color and low-income neighborhoods. As health care professionals, pharmacists are in a key position to play a major role in improving health outcomes for disadvantaged populations. Health equity means that all patients have a fair and just opportunity to be healthy and achieve wellness. This requires a proactive approach to acknowledging and navigating racial, social, economic, and environmental obstacles to good health.

Attendees will be able to:

  • Identify innovative programs to help address racial as well as income-related health disparities
  • Describe how advanced analytics can help identify at-risk populations and target individual patient needs
  • Develop short-term and long-term success metrics that reflect program impact


Stacey Emmons, PharmD
Director of Patient Outcomes Performance and Adherence

Stacey Emmons, PharmD, is the Director of Patient Outcomes Performance and Adherence at Walgreens. Dr. Emmons has worked in the community pharmacy setting for over 15 years in various positions and throughout her career continues to be an advocate for patient healthcare and health outcomes provided through the profession of pharmacy. Stacey leads a team of pharmacy professionals dedicated to the improvement of health outcomes through a differentiated, Omni channel experience. Dr. Emmons is a member of the PQA Education Advisory Council and the National Medication Therapy Management Advisory Board.

Michael Taitel, PhD
Senior Director of Health Analytics, Research & Reporting

Dr. Michael Taitel is a Senior Director of Health Analytics, Research & Reporting at Walgreens and has been with the company since 2010. He leads a multidisciplinary team of data and social scientists responsible for conducting clinical outcomes studies, predictive analytics, and economic modeling to support Walgreen’s health and wellness innovations in retail pharmacy and digital health. He holds a doctorate in experimental health psychology and offers insights into conducting behavioral and clinical research in applied settings. He has presented and published numerous studies on health & productivity, medication adherence, vaccinations, and health disparities.